Abstract 2125P
Background
Hypovitaminosis D can have a negative impact in patients (pts) with cancer. We hypothesized that systematic vitamin D repletion could improve outcomes in pts receiving immune-checkpoint inhibitors (ICIs).
Methods
We planned a prospective observational study (PROVIDENCE) to investigate vitamin D levels in pts with advanced cancer receiving ICIs (cohort 1 at treatment initiation, cohort 2 during treatment) and the impact of systematic repletion in the case of hypovitaminosis on survival and toxicity outcomes. In an exploratory analysis, we compared clinical outcomes of cohort 1 with a control cohort of pts followed at the participating centers who did not receive systematic vitamin D repletion.
Results
Overall, 164 pts were prospectively recruited. In cohort 1, consisting of 101 pts with 94.1% hypovitaminosis (≤30 ng/ml) at baseline, adequate repletion with cholecalciferol was obtained in 70.1% at the three months re-assessment. Cohort 2 consisted of 63 pts assessed for vitamin D at a median time of 3.7 months since immunotherapy initiation, with no pts having adequate levels (>30 ng/ml). Even in cohort 2, systematic supplementation led to adequate levels in 77.8% of pts at the three months re-assessment. Compared to a retrospective control group of 238 pts without systematic vitamin D repletion, PROVIDENCE cohort 1 showed longer OS and time to treatment failure (TTF), p=0.013 and p=0.017. The IPTW-fitted multivariable Cox regression confirmed the significantly decreased risk of death (HR 0.55, 95%CI: 0.34-0.90) and treatment discontinuation (HR 0.61, 95%CI: 0.40-0.91) for pts from PROVIDENCE cohort 1 in comparison to the control cohort. In the context of longer treatment exposure, the cumulative incidence of any grade irAEs was higher in the PROVIDENCE cohort 1 compared to the control cohort. Nevertheless, pts from cohort 1 experienced a significantly decreased risk of all grade thyroid irAEs than the control cohort (OR 0.16, 95%CI: 0.03-0.85).
Conclusions
The PROVIDENCE study suggests the potential positive impact of early systematic vitamin D supplementation on outcome of pts with advanced cancer receiving ICIs and support adequate repletion as a possible prophylaxis for thyroid irAEs.
Clinical trial identification
Not Applicable
Editorial acknowledgement
Not applicable
Legal entity responsible for the study
University Hospital of Parma.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2076P - Topical diclofenac for prevention of HFS in patients receiving capecitabine monotherapy: An exploratory subgroup analysis of the D-ToRCH phase III trial
Presenter: Akhil Santhosh
Session: Poster session 06
2077P - A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Presenter: Triantafylos Didangelos
Session: Poster session 06
2078P - Evaluation of chemotherapy-induced nausea and vomiting beyond the delayed phase: Results of a survey of healthcare providers in Japan
Presenter: Florian Scotté
Session: Poster session 06
2079P - Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Presenter: Maria del Carmen Beato Zambrano
Session: Poster session 06
2080P - Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Presenter: Olivia Rohr
Session: Poster session 06
2081P - The therapeutic effect of anti-inflammatory tripeptide cream on hand-foot syndrome related to anticancer drugs: A prospective, randomized, placebo-controlled pilot trial
Presenter: Yaewon Yang
Session: Poster session 06
2082P - TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Presenter: Marco Filetti
Session: Poster session 06
2083P - Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Presenter: Rocío Martín Lozano
Session: Poster session 06
2084P - Cardiovascular (CV) mortality among metastatic cancer patients: A retrospective cohort study
Presenter: Irbaz Riaz
Session: Poster session 06